SCHEMBL25857654

SCHEMBL25857654

CC(=O)c1cc(NC(=O)c2csc(C)n2)cn1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 1/20 0.45
▸ TLR7 Q9NYK1 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ DYRK1A Q13627 1/20 0.43
▸ KCNH2 Q12809 2/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ BACE1 P56817 2/20 0.41
▸ GRM7 Q14831 1/20 0.39
▸ GRM4 Q14833 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HTR1A P08908 1/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ HTR1B P28222 1/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25857901 0.86 TLR7 (0.43) CBLBTLR7KDM4EGSK3BDYRK1A
SCHEMBL25852549 0.86 MAPT (0.40) CBLBKDM4EBACE1HIF1ACYP1A2
SCHEMBL25852674 0.84 MAPT (0.39) CBLBKDM4EBACE1HIF1ACYP1A2
SCHEMBL19636636 0.83 DHFR (0.40) KDM4EDYRK1AHIF1A
SCHEMBL19636924 0.83 DHFR (0.40) KDM4EDYRK1AHIF1A
SCHEMBL19636632 0.82 DHFR (0.40) KDM4EDYRK1AHIF1ACYP1A2CYP2C19
SCHEMBL14543374 0.81 CBLB (0.40) CBLBTLR7KDM4EGSK3BDYRK1A
SCHEMBL14072184 0.74 MAPT (0.43) KDM4ECYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL19350927 0.74 TOP1 (0.43) KDM4EBACE1HIF1A
SCHEMBL12934350 0.73 HDAC1 (0.41) KDM4EBACE1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458069-B1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS INC (US) 2023-07-05 — — EP disclosed
Send feedback